ArticleFrontiers in pharmacology2015

The casein kinase 2 inhibitor, CX-4945, as an anti-cancer drug in treatment of human hematological malignancies.

Hae J Chon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.